Image

Diagnostic Value of Deep Learning-Based Rapid MRI in Preoperative Evaluation of Acute Cholecystitis

Diagnostic Value of Deep Learning-Based Rapid MRI in Preoperative Evaluation of Acute Cholecystitis

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This is a single-center, prospective observational study at Peking Union Medical College Hospital. The main goal is to evaluate the image quality and clinical value of a new fast abdominopelvic MRI sequence that uses deep learning-based reconstruction.

The study will include adult patients (18 years or older) who need an MRI scan of the abdomen or pelvis as part of their routine care. These patients will receive both the standard MRI sequence and the new fast sequence, with the goal of comparing the two. The fast sequence is designed to be shorter (5-8 minutes) while maintaining or improving image quality, which can help reduce patient discomfort and motion-related artifacts.

Radiologists will assess the quality of the images from both sequences. The study will also look at how well the fast sequence can detect common abdominal and pelvic diseases, such as gallstones, inflammation, and tumors. This study does not involve new drugs, invasive procedures, or changes to standard care. No additional risks to patients are expected beyond those of a standard MRI scan.

Eligibility

Inclusion Criteria:

  • Age ≥ 18 years
  • Clinical indication for abdominopelvic MRI examination
  • Able to understand and sign the informed consent form
  • Able to lie supine and cooperate with breath-holding/respiratory commands during MRI

Exclusion Criteria:

  • Presence of absolute contraindications to MRI (e.g., pacemaker, ferromagnetic foreign body, severe claustrophobia)
  • Inability to complete the MRI scan due to severe pain, instability, or altered mental status
  • Pregnant or breastfeeding women (unless explicitly approved by protocol)
  • Previous abdominal/pelvic surgery with contraindications to MRI sequences

Study details
    Acute Cholecystitis

NCT07551375

Peking Union Medical College Hospital

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.